But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good standing with physicians.

Bayer's Monsanto has sued Pfizer, BioNTech and Moderna for allegedly misusing its messenger RNA technology in COVID vaccines.

Both the CEOs of Moderna and Pfizer said a booster dose of their respective COVID-19 vaccines could be required as soon as September for those who were among the earliest vaccinated. During an Axios ...

As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...

Bayer has filed separate lawsuits against the creators of three COVID-19 vaccines, claiming they violated intellectual property developed by Monsanto, the crop science company the German company ...

The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...

Stream Connecticut News for free, 24/7, wherever you are. The new vaccines, which target the omicron variant XBB.1.5, are approved for people 12 and older and are authorized under emergency use for ...

Moderna’s 2028 cash breakeven guidance may not be feasible, analysts say.

WASHINGTON, D.C. — U.S. health officials announced Wednesday that booster shots will soon be available to Americans who have received the COVID-19 vaccines made by Pfizer and Moderna. Officials with ...